TickerFactsScreenerDevelopers

CASI Pharmaceuticals, Inc. (CASIF) — Operating Income

Annual figures by fiscal year, from SEC filings.

2020: -$52.78M2021: -$41.52M2022: -$34.03M2023: -$25.08M2024: -$39.62M2025: -$45.01M-$45.01M
2020Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$45.01M-13.6%
2024-$39.62M-58.0%
2023-$25.08M+26.3%
2022-$34.03M+18.0%
2021-$41.52M+21.3%
2020-$52.78M—